Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'mi 773'

Search results for: 'mi 773'

6 Items

per page
  1. Empagliflozin (BI 10773)
    A4601 Empagliflozin (BI 10773)
     2 Citation
    Summary: SGLT-2 inhibitor for oral treatment of type 2 diabetes
      insoluble in H2O; ≥20.75 mg/mL
  2. PF-477736
    B1437 PF-477736
    Target: Chk
    Summary: Chk1 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥5.24 mg/mL
  3. MI-77301 (SAR405838)
    B4984 MI-77301 (SAR405838)
    Summary: orally available MDM2 antagonist
      ≥17.2 mg/mL
  4. BAY-u 9773
    B7284 BAY-u 9773
    Summary: Antagonist of CysLT1/CysLT2 receptors
      Soluble in ethanol
  5. MI-773
    BA3460 MI-773
    Summary: MI-773 is a potent protein-protein interaction (PPI) inhibitor with high binding affinity for specific (K=8.2nM).
  6. MK-0773
    BA9190 MK-0773
    Summary: MK-0773 is a selective androgen receptor modulator.

6 Items

per page